DAP rep urges for adherence to evidence in Covid-19 treatment, as Pakatan colleagues try to lobby for ivermectin in Parliament | Malaysia malaymail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaymail.com Daily Mail and Mail on Sunday newspapers.
PUTRAJAYA: The parasitic medication Ivermectin is not being used at private hospitals to treat Covid-19 patients, says the Association of Private Hospitals Malaysia.
Its president Datuk Dr Kuljit Singh said the association has consulted most of its 152 members and none of them are using the medication.
“Private hospitals have been treating Covid-19 patients since January using treatment protocols which are approved with evidence-based guidelines by the Health Ministry and international medical societies, and Ivermectin is not included.
“The association assures the public that none of its members have prescribed Ivermectin to their patients for the purpose of treating Covid-19 in any category.
Private hospitals not using Ivermectin for Covid-19 patients, says group | Daily Express Online dailyexpress.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexpress.com.my Daily Mail and Mail on Sunday newspapers.
Private hospitals not using Ivermectin for Covid-19 patients: APHM thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.
Copy URL
APHM president Dr Kuljit Singh says most of its 152 members consulted have said they are not using Ivermectin for treating Covid-19, in any category. – EPA pic, July 26, 2021.
PRIVATE hospitals in the country are not using the anti-parasitic medication Ivermectin to treat their Covid-19 patients, the Association of Private Hospitals Malaysia (APHM) said today.
APHM president Dr Kuljit Singh said most of its 152 members consulted have said they are not using Ivermectin for treating Covid-19, in any category.
Effective July 2018, access to full reports will only be available with a subscription. Sign-up now and enjoy one (1) week free access!